THOUSAND OAKS, Calif., Feb.
Novartis shows continued commitment in Japan with Lucentis® approval in fourth Japanese indication, diabetic macular edema
-- Ramucirumab Improved Survival in Second-Line Study of Patients with Non-Small Cell Lung Cancer --
Metro® Using Machine-to-Machine Technology to Make Vital Patient Data Accessible at the Point of Care
Mapi Pharma Granted United States Patent Covering the Process for the Preparation of Fingolimod for Multiple Sclerosis
Shire submits Elvanse® (lisdexamfetamine dimesylate) for an adult licence in the UK, Denmark and Sweden
FDA Issues Complete Response Letters for Use of XARELTO® (rivaroxaban) to Reduce the Risk of Secondary Cardiovascular Events and Stent Thrombosis in Patients with Acute Coronary Syndrome
TUCSON, Ariz., Feb.
OncoGenex Announces Target Number of Events Reached in Phase 3 SYNERGY Trial of Custirsen in Metastatic Castrate-Resistant Prostate Cancer
BOTHELL, Wash. and VANCOUVER, British Columbia, Feb.
Tulane University School of Medicine participates in pilot program
Lilly Diabetes Donates 91 Scholarships to Support the American Diabetes Association's Diabetes Summer Camp Program
More than half a million dollars donated to help children with diabetes attend camp since 2008